Aquestive Therapeutics, Inc.AQST

時価総額
PER
2018年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
2023年
12月31日
Revenues675346514851
Manufacture and supply2120-1519-
Manufacture and supply--13--21
Research and development232120171713
Selling, general and administrative726456535332
Total costs and expenses11610589869066
Total costs and expenses--89--66
Loss from operations-49-53-43-35-42-15
Loss from operations-49-53-43-35-42-15
Interest expense89111076
Interest expense related to the sale of future revenue---1260
Interest expense related to royalty obligations, net-----1
Interest and Other Income11-00-
Interest expense related to the sale of future revenue---1260
Loss on the extinguishment of debt--5--14--1
Interest And Other Income, Net-----16
Loss on the extinguishment of debt--5--14--1
Net loss before income taxes-61-66-56-71-54-8
Interest expense89111076
Interest expense related to the sale of future revenue---1260
Interest expense related to royalty obligations, net-----1
Interest and Other Income11-00-
Interest expense related to the sale of future revenue---1260
Loss on the extinguishment of debt--5--14--1
Interest And Other Income, Net-----16
Loss on the extinguishment of debt--5--14--1
Net loss before income taxes-61-66-56-71-54-8
Income taxes-----0
Net loss before income taxes-61-66-56-71-54-8
Net loss-61-66-56-71-54-8
Income taxes-----0
Comprehensive loss-61-66-56-71-54-8
Net loss-61-66-56-71-54-8
Earnings Per Share, Basic----1.85-1.12-0.13
Earnings Per Share, Diluted----1.85-1.12-0.13
Comprehensive loss-61-66-56-71-54-8
Earnings Per Share, Basic----1.85-1.12-0.13
Earnings Per Share, Diluted----1.85-1.12-0.13